When Carla Sobrini's daughter Emilia failed her newborn hearing test, she had no idea that a virus she'd unknowingly caught ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Comp ...

Research from the Keck School of Medicine has found that COVID-19 therapies cause few serious side effects, based on an ...

The influenza A virus remains a major global health concern due to its role in seasonal outbreaks and its potential to ...